FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...
CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.
The purpose of the FDA meeting was to discuss the FDA’s expectations with respect to the requirements necessary for the granting of traditional approval of Olvi-Vec. In response to a question ...
The purpose of the meeting was to reach agreement with the FDA on the proposed content and format of the Company’s planned sNDA submission including the clinical and nonclinical requirements.
? Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ? CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | ...
Days after the U.S. FDA cancelled an annual meeting to discuss the makeup of the following season's flu vaccine, FDA Commissioner nominee Marty Makary pledged to review that decision if he is ...
In order for flu vaccines to be sold in the US, they must contain strains that are officially selected by the FDA. That decision typically comes after a meeting of the World Health Organization ...
In a letter sent on Friday to Dr. Marty Makary, President Trump's nominee for FDA Commissioner, the senators criticized the cancellation, pushing the importance of the annual meeting. "The cancell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results